MedTrace Logo

Microfinance and Health Intervention Trial for Youth in Dar es Salaam, Tanzania

NCT01865383 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2623

Last updated 2018-06-15

No results posted yet for this study

Summary

Young men who are members of the camps randomized to receive a microfinance and health leadership intervention will have a lower incidence of sexually transmitted infections (Neisseria gonorrhea (NG), Chlamydia trachomatis (CT) and Trichomonas vaginalis (TV) and report perpetrating less physical or sexual violence against sexual partners as compared to young men who are members of camps not randomized to receive the intervention.

Conditions

  • Sexually Transmitted Infections
  • Domestic Violence

Interventions

BEHAVIORAL

Microfinance and Health Leadership

Microfinance and Health Leadership: Participants will be eligible to receive small loans and business training as part of the microfinance component. Nominated leaders in camps will receive health leadership training on prevention of HIV risk behaviors and gender based violence perpetration, and then pass on knowledge to camp members.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Muhimbili University of Health and Allied Sciences

    collaborator OTHER

  • American University

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Suzanne Maman, PhD · UNC Chapel Hill

  • Lusajo Kajula-Maonga, MA · Muhimbilit University of Health and Allied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-03-01
Completion
2017-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01865383 on ClinicalTrials.gov